<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Genetics</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Genetics</journal-title><trans-title-group xml:lang="ru"><trans-title>Генетика</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0016-6758</issn><issn publication-format="electronic">3034-5103</issn><publisher><publisher-name xml:lang="en">The Russian Academy of Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">666948</article-id><article-id pub-id-type="doi">10.31857/S0016675824040065</article-id><article-id pub-id-type="edn">creovs</article-id><article-categories><subj-group subj-group-type="toc-heading"><subject>ГЕНЕТИКА ЧЕЛОВЕКА</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Frequent genetic variants of autosomal recessive non-syndromic forms of inherited retinal diseases in the Russian Federation</article-title><trans-title-group xml:lang="ru"><trans-title>Частые генетические варианты аутосомно-рецессивных несиндромальных форм наследственных заболеваний сетчатки у жителей Российской Федерации</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Ogorodova</surname><given-names>N. Yu.</given-names></name><name xml:lang="ru"><surname>Огородова</surname><given-names>Н. Ю.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>ogorodova@med-gen.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Stepanova</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Степанова</surname><given-names>А. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>ogorodova@med-gen.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shchagina</surname><given-names>O. A.</given-names></name><name xml:lang="ru"><surname>Щагина</surname><given-names>О. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>ogorodova@med-gen.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kadyshev</surname><given-names>V. V.</given-names></name><name xml:lang="ru"><surname>Кадышев</surname><given-names>В. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>ogorodova@med-gen.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Polyakov</surname><given-names>A. V.</given-names></name><name xml:lang="ru"><surname>Поляков</surname><given-names>А. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>ogorodova@med-gen.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Research Centre for Medical Genetics</institution></aff><aff><institution xml:lang="ru">Медико-генетический научный центр им. академика Н.П. Бочкова</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2024-04-11" publication-format="electronic"><day>11</day><month>04</month><year>2024</year></pub-date><volume>60</volume><issue>4</issue><fpage>69</fpage><lpage>83</lpage><history><date date-type="received" iso-8601-date="2025-02-26"><day>26</day><month>02</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Russian Academy of Sciences</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2024, Российская академия наук</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Russian Academy of Sciences</copyright-holder><copyright-holder xml:lang="ru">Российская академия наук</copyright-holder></permissions><self-uri xlink:href="https://transsyst.ru/0016-6758/article/view/666948">https://transsyst.ru/0016-6758/article/view/666948</self-uri><abstract xml:lang="en"><p>Inherited retinal diseases (IRDs) are a clinically heterogeneous group of retinal pathologies associated with vision loss due to dysfunction or degeneration of photoreceptor and retinal pigment epithelium. Autosomal recessive forms of IRDs account for more than 55% of all diseases in this group on average worldwide. This study presents data on frequent pathogenic and likely pathogenic variants in recessive IRDs genes obtained from a retrospective analysis of high-throughput sequencing data from a large Russian cohort of patients with suspected hereditary non-syndromic retinal pathology. Data from 1470 unrelated patients were analyzed. Pathogenic and likely pathogenic variants were identified in the zygosity required for the development of the diseasein 643 patients (43.74%). It was found that 9 genes (<italic>ABCA4</italic>, <italic>CNGB3</italic>, <italic>USH2A</italic>, <italic>RPE65</italic>, <italic>CRB1</italic>, <italic>CNGA3</italic>, <italic>CEP290</italic>, <italic>GUCY2D</italic>, <italic>PDE6H</italic>) account for 73.3% of all molecularly confirmed cases of IRDs in Russian patients. An analysis of the spectrum of nucleotide variants of these genes was carried out, and 17 variants were identified that occur with an allelic frequency of more than 1% for each gene. In light of obtained data, the diagnostic systems based on the multiplex ligation-dependent probe amplification reaction (MLPA) were developed. The informativity of the two systems for diagnosing autosomal recessive non-syndromic forms of inherited retinal diseases is 16.4%, the informativity for all forms of non-syndromic retinal diseases exceeds 7%. For a group of patients with achromatopsia, a study using one of the systems will make it possible to establish a diagnosis in 62.5% of cases.</p></abstract><trans-abstract xml:lang="ru"><p>Наследственные заболевания сетчатки (НЗС) представляют собой клинически гетерогенную группу патологий сетчатки, сопровождающихся потерей зрения вследствие дисфункции или дегенерации фоторецепторных клеток и клеток пигментного эпителия сетчатки. На долю аутосомно-рецессивных форм НЗС в среднем в мире приходится более 55% всех заболеваний этой группы. В настоящем исследовании представлены частые патогенные и вероятно патогенные варианты в генах, ответственных за аутосомно-рецессивные НЗС, полученные на основе ретроспективного анализа данных высокопроизводительного секвенирования большой российской когорты пациентов с подозрением на наследственную несиндромальную патологию сетчатки. Были проанализированы данные 1470 неродственных пациентов. У 643 (43,74%) были выявлены патогенные и вероятно патогенные варианты в зиготности, необходимой для развития заболевания. Установлено, что на долю девяти генов (<italic>ABCA4</italic>, <italic>CNGB3</italic>, <italic>USH2A</italic>, <italic>RPE65</italic>, <italic>CRB1</italic>, <italic>CNGA3</italic>, <italic>CEP290</italic>, <italic>GUCY2D</italic>, <italic>PDE6H)</italic> приходится 73.3% всех молекулярно-подтвержденных случаев НЗС у российских пациентов. Был проведен анализ спектров нуклеотидных вариантов данных генов и выявлено 17 вариантов, встречающихся с аллельной частотой более 1% для каждого из генов. На основании полученных данных были разработаны диагностические системы на основе аллель-специфичной мультиплексной проба-зависимой лигазной реакции (MLPA). Информативность двух систем для диагностики аутосомно-рецессивных несиндромальных форм наследственных заболеваний сетчатки составляет 16.4%, информативность для всех форм несиндромальных заболеваний сетчатки превышает 7%. Для группы пациентов с ахроматопсией исследование с использованием одной из систем позволит установить диагноз в 62.5% случаев.</p></trans-abstract><kwd-group xml:lang="en"><kwd>inherited retinal diseases</kwd><kwd>frequent recessive variants</kwd><kwd>achromatopsia</kwd><kwd>Leber congenital amaurosis</kwd><kwd>Stargardtdisease</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>наследственные заболевания сетчатки</kwd><kwd>частые рецессивные варианты</kwd><kwd>ахроматопсия</kwd><kwd>врожденный амавроз Лебера</kwd><kwd>болезнь Штаргардта</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Hanany M., Rivolta C., Sharon D. Worldwide carrier frequency and genetic prevalence of autosomal recessive inherited retinal diseases // Proc. Natl Acad. Sci. USA. 2020. V. 117. № 5. P. 2710−2716. https://doi.org/10.1073/pnas.1913179117</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Jespersgaard C., Fang M., Bertelsen M. et al. Molecular genetic analysis using targeted NGS analysis of 677 individuals with retinal dystrophy // Sci. Rep. 2019. V. 9. № 1. P. 1219. https://doi.org/10.1038/s41598-018-38007-2</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Sharon D., Ben-Yosef T., Goldenberg-Cohen N. et al. A nationwide genetic analysis of inherited retinal diseases in Israel as assessed by the Israeli inherited retinal disease consortium (IIRDC) // Hum. Mutat. 2020. V. 41. № 1. P. 140–149. https://doi.org/10.1002/humu.23903</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Weisschuh N., Obermaier C.D., Battke F. et al. Genetic architecture of inherited retinal degeneration in Germany: A large cohort study from a single diagnostic center over a 9-year period // Hum. Mutat. 2020. V. 41. № 9. P. 1514–1527. https://doi.org/10.1002/humu.24064</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Rivolta C., Sharon D., DeAngelis M.M., Dryja T.P. Retinitis pigmentosa and allied diseases: numerous diseases, genes, and inheritance patterns // Hum. Mol. Genet. 2002. V. 11. № 10. P. 1219–1227. https://doi.org/10.1093/hmg/11.10.1219</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Martin-Merida I., Avila-Fernandez A., Del Pozo-Valero M. et al. Genomic landscape of sporadic retinitis pigmentosa: Findings from 877 Spanish cases // Ophthalmology. 2019. V. 126. № 8. P. 1181–1188. https://doi.org/10.1016/j.ophtha.2019.03.018</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Gao F.J., Li J.K., Chen H. et al. Genetic and clinical findings in a large cohort of Chinese patients with suspected retinitis pigmentosa // Ophthalmology. 2019. V. 126. №11. P. 1549–1556. https://doi.org/10.1016/j.ophtha.2019.04.038</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Koyanagi Y., Akiyama M., Nishiguchi K.M. et al. Genetic characteristics of retinitis pigmentosa in 1204 Japanese patients // J. Med. Genet. 2019. V. 56. № 10. P. 662–670. https://doi.org/10.1136/jmedgenet-2018-105691</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Avela K., Salonen-Kajander R., Laitinen A. et al. The genetic aetiology of retinal degeneration in children in Finland – new founder mutations identified //Acta Ophthalmol. 2019. V. 97. № 8. P. 805–814. https://doi.org/10.1111/aos.14128</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Jaakson K., Zernant J., Külm M. et al. Genotyping microarray (gene chip) for the ABCR (ABCA4) gene // Hum. Mutat. 2003. V. 22. № 5. P. 395–403. https://doi.org/10.1002/humu.10263</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Степанова А.А., Кадышев В.В., Щагина О.А., Поляков А.В. Селективный скрининг больных наследственными дегенерациями сетчатки для выявления целевой группы для генотерапии воретигеном непарвовеком // Медицинская генетика. 2022. Т. 21. № 10. С. 51–55. https://doi.org/10.25557/2073-7998.2022.10.51-55).</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Zhong Z., Rong F., Dai Y. et al. Seven novel variants expand the spectrum of RPE65-related Leber congenital amaurosis in the Chinese population // Mol. Vis. 2019. V. 25. P. 204–214.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Вассерман Н.Н., Щагина О.А., Поляков А.В. Результаты использования новой медицинской технологии “Система детекции наиболее частых мутаций гена FGFR3, ответственного за ахондроплазию и гипохондроплазию” в ДНК-диагностике // Мед. генетика. 2016. Т. 15. № 2. С.37–41.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Гундорова П., Степанова А.А., Щагина О.А., Поляков А.В. Результаты использования новых медицинских технологий “Детекция основных точковых мутаций гена PAH методом мультиплексной лигазной реакции” и “Детекция десяти дополнительных точковых мутаций гена PAH методом мультиплексной лигазной реакции” в ДНК-диагностике фенилкетонурии // Мед. генетика. 2016. Т. 15. № 2. С. 29–36.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Рыжкова О.П., Кардымон О.Л., Прохорчук Е.Б. и др. Руководство по интерпретации данных последовательности ДНК человека, полученных методами массового параллельного секвенирования (MPS) (редакция 2018, версия 2) // Мед. генетика. 2019. Т. 18. № 2. С. 3–23. https://doi.org/10.25557/2073-7998.2019.02.3-23</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Colombo L., Maltese P.E., Castori M. et al. Molecular epidemiology in 591 Italian probands with nonsyndromic retinitis pigmentosa and Usher syndrome // Invest. Ophthalmol. Vis. Sci. 2021. V. 62. № 2. https://doi.org/10.1167/iovs.62.2.13</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Shatokhina O., Galeeva N., Stepanova A. et al. Spectrum of genes for non-GJB2-related non-syndromic hearing loss in the Russian population revealed by a targeted deafness gene panel // Int. J. Mol. Sci. 2022. V. 23. № 24. P. 15748. https://doi.org/10.3390/ijms232415748</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>den Hollander A.I., Koenekoop R.K., Yzer S. et al. Mutations in the CEP290 (NPHP6) gene are a frequent cause of Leber congenital amaurosis // Am. J. Hum. Genet. 2006. V. 79. № 3. P. 556–561. https://doi.org/10.1086/507318</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Avela K., Sankila E.M., Seitsonen S. et al. A founder mutation in CERKL is a major cause of retinal dystrophy in Finland // Acta Ophthalmol. 2018. V. 96. № 2. P. 183–191. https://doi.org/10.1111/aos.13551</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Lenassi E., Vincent A., Li Z. et al.A detailed clinical and molecular survey of subjects with nonsyndromic USH2A retinopathy reveals an allelic hierarchy of disease-causing variants // Eur. J. Hum. Genet. 2015. V. 23. № 10. P. 1318–1327. https://doi.org/10.1038/ejhg.2014.283</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>van Wijk E., Pennings R.J., teBrinke H. et al. Identification of 51 novel exons of the Usher syndrome type 2A (USH2A) gene that encode multiple conserved functional domains and that are mutated in patients with Usher syndrome type II // Am. J. Hum. Genet. 2004. V. 74. № 4. P. 738–744. https://doi.org/10.1086/383096</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Ivanova M.E., Trubilin V.N., Atarshchikov D.S. et al. Genetic screening of Russian Usher syndrome patients toward selection for gene therapy // Ophthalmic Genet. 2018. V. 39. № 6. P. 706–713. https://doi.org/10.1080/13816810.2018.1532527</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Nakamura M., Lin J., Nishiguchi K. et al. Bietti crystalline corneoretinal dystrophy associated with CYP4V2 gene mutations // Adv. Exp. Med. Biol. 2006. V. 572. P. 49–53. https://doi.org/10.1007/0-387-32442-9_8</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Rivera A., White K., Stöhr H. et al. A comprehensive survey of sequence variation in the ABCA4 (ABCR) gene in Stargardt disease and age-related macular degeneration // Am. J. Hum. Genet. 2000. V. 67. № 4. P. 800–813. https://doi.org/10.1086/303090</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Ścieżyńska A., Oziębło D., Ambroziak A.M. et al. Next-generation sequencing of ABCA4: High frequency of complex alleles and novel mutations in patients with retinal dystrophies from Central Europe // Exp. Eye Res. 2016. V. 145. P. 93–99. https://doi.org/10.1016/j.exer.2015.11.011</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Roberts L.J., Nossek C.A., Greenberg L.J., Ramesar R.S. Stargardt macular dystrophy: Common ABCA4 mutations in South Africa-establishment of a rapid genetic test and relating risk to patients // Mol. Vis. 2012. V. 18. P. 280–289.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Fujinami K., Sergouniotis P.I., Davidson A.E. et al. Clinical and molecular analysis of Stargardt disease with preserved foveal structure and function // Am. J. Ophthalmol. 2013. V. 156. № 3. P. 487–501. https://doi.org/10.1016/j.ajo.2013.05.003</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Valverde D., Riveiro-Alvarez R., Bernal S. et al. Microarray-based mutation analysis of the ABCA4 gene in Spanish patients with Stargardt disease: Evidence of a prevalent mutated allele // Mol. Vis. 2006. V. 12. P. 902–908.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Hirji N., Aboshiha J., Georgiou M. et al. Achromatopsia: clinical features, molecular genetics, animal models and therapeutic options // Ophthalmic Genet. 2018. V. 39. № 2. P. 149–157. https://doi.org/10.1080/13816810.2017.1418389</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Kohl S., Varsanyi B., Antunes G.A. et al. CNGB3 mutations account for 50% of all cases with autosomal recessive achromatopsia // Eur. J. Hum. Genet. 2005. V. 13. № 3. P. 302–308. https://doi.org/10.1038/sj.ejhg.5201269</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Sun W., Li S., Xiao X., et al. Genotypes and phenotypes of genes associated with achromatopsia: A reference for clinical genetic testing // Mol. Vis. 2020. V. 26. P. 588–602.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Mayer A.K., Van Cauwenbergh C., Rother C. et al. CNGB3 mutation spectrum including copy number variations in 552 achromatopsia patients // Hum.Mutat. 2017. V. 38. № 11. P. 1579–1591. https://doi.org/10.1002/humu.23311</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Wissinger B., Gamer D., Jägle H. et al. CNGA3 mutations in hereditary cone photoreceptor disorders // Am. J. Hum. Genet. 2001. V. 69. № 4. P. 722–737. https://doi.org/10.1086/323613</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Kohl S., Coppieters F., Meire F. et al. A nonsense mutation in PDE6H causes autosomal-recessive incomplete achromatopsia // Am. J. Hum. Genet. 2012. V. 91. № 3. P. 527–532. https://doi.org/10.1016/j.ajhg.2012.07.006</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Holtan J.P., Selmer K.K., Heimdal K.R., Bragadóttir R. Inherited retinal disease in Norway – a characterization of current clinical and genetic knowledge // Acta Ophthalmol. 2020. V. 98. № 3. P. 286–295. https://doi.org/10.1111/aos.14218</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Pedurupillay C.R., Landsend E.C., Vigeland M.D. et al. Segregation of incomplete achromatopsia and alopecia due to PDE6H and LPAR6 variants in a consanguineous family from Pakistan // Genes (Basel). 2016. V. 7. № 8. https://doi.org/10.3390/genes7080041</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Lopez-Rodriguez R., Lantero E., Blanco-Kelly F. et al. RPE65-related retinal dystrophy: Mutational and phenotypic spectrum in 45 affected patients // Exp. Eye Res. 2021. V. 212. https://doi.org/10.1016/j.exer.2021.108761</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Sallum J.MF., Kaur V.P., Shaikh J. et al. Epidemiology of Mutations in the 65-kDa Retinal Pigment Epithelium (RPE65) Gene-Mediated Inherited Retinal Dystrophies: A Systematic Literature Review // Adv. Ther. 2022. V. 39. № 3. P. 1179–1198. https://doi.org/10.1007/s12325-021-02036-7</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Zobor D., Brühwiler B., Zrenner E. et al. Genetic and clinical profile of retinopathies due to disease-causing variants in Leber congenital amaurosis (LCA)-associated genes in a large German cohort // Int. J. Mol. Sci. 2023. V. 24. № 10. https://doi.org/10.3390/ijms24108915</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Dharmaraj S.R., Silva E.R., Pina A.L. et al. Mutational analysis and clinical correlation in Leber congenital amaurosis // Ophthalmic Genet. 2000. V. 21. № 3 P. 135–150. https://doi.org/10.1076/1381-6810(200009)2131-ZFT135</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Chen Y., Zhang Q., Shen T. et al. Comprehensive mutation analysis by whole-exome sequencing in 41 Chinese families with Leber congenital amaurosis // Invest. Ophthalmol. Vis. Sci. 2013. V. 54. № 6. P. 4351–4357. https://doi.org/10.1167/iovs.13-11606</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Skorczyk-Werner A., Sowińska-Seidler A., Wawrocka A. et al. Molecular background of Leber congenital amaurosis in a Polish cohort of patients-novel variants discovered by NGS // J. Appl. Genet. 2023. V. 64. № 1. P. 89–104. https://doi.org/10.1007/s13353-022-00733-9</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Vallespin E., Cantalapiedra D., Riveiro-Alvarez R. et al. Mutation screening of 299 Spanish families with retinal dystrophies by Leber congenital amaurosis genotyping microarray // Invest. Ophthalmol. Vis. Sci. 2007. V. 48. № 12. P. 5653–5661. https://doi.org/10.1167/iovs.07-0007</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Thompson J.A., De Roach J.N., McLaren T.L. et al. The genetic profile of Leber congenital amaurosis in an Australian cohort // Mol. Genet. Genomic Med. 2017. V. 5. № 6. P. 652–667. https://doi.org/10.1002/mgg3.321</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Coppieters F., Casteels I., Meire F.et al. Genetic screening of LCA in Belgium: Predominance of CEP290 and identification of potential modifier alleles in AHI1 of CEP290-related phenotypes // Hum. Mutat. 2010. V. 31. № 10. P. E1709–1766. https://doi.org/10.1002/humu.21336</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Vallespin E., Lopez-Martinez M.A., Cantalapiedra D. et al. Frequency of CEP290 c.2991_1655A&gt;G mutation in 175 Spanish families affected with Leber congenital amaurosis and early-onset retinitis pigmentosa // Mol. Vis. 2007. V. 13. P. 2160–2162.</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Sundaresan P., Vijayalakshmi P., Thompson S.et al. Mutations that are a common cause of Leber congenital amaurosis in northern America are rare in southern India // Mol. Vis. 2009. V. 15. P. 1781–1787.</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Seong M.W., Kim S.Y., Yu Y.S.et al. Molecular characterization of Leber congenital amaurosis in Koreans // Mol. Vis. 2008. V. 14. P. 1429–1436.</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Corton M., Tatu S.D., Avila-Fernandez A.et al. High frequency of CRB1 mutations as cause of Early-Onset Retinal Dystrophies in the Spanish population // Orphanet J. Rare Dis. 2013. V. 8. https://doi.org/10.1186/1750-1172-8-20</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Bujakowska K., Audo I., Mohand-Saïd S. et al. CRB1 mutations in inherited retinal dystrophies // Hum. Mutat. 2012. V. 33. № 2. P. 306–315. https://doi.org/10.1002/humu.21653</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Huang X.F., Huang F., Wu K.C. et al. Genotype–phenotype correlation and mutation spectrum in a large cohort of patients with inherited retinal dystrophy revealed by next-generation sequencing // Genet. Med. 2015. V. 17. № 4. P. 271–278. https://doi.org/10.1038/gim.2014.138</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Hanein S., Perrault I., Olsen P. et al. Evidence of a founder effect for the RETGC1 (GUCY2D) 2943DelG mutation in Leber congenital amaurosis pedigrees of Finnish origin // Hum. Mutat. 2002. V. 20. № 4. P. 322–323. https://doi.org/10.1002/humu.9067</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Bouzia Z., Georgiou M., Hull S. et al. GUCY2D-associated Leber congenital amaurosis: A retrospective natural history study in preparation for trials of novel therapies // Am. J. Ophthalmol. 2020. V. 210. P. 59–70. https://doi.org/10.1016/j.ajo.2019.10.019</mixed-citation></ref></ref-list></back></article>
